期刊文献+

口腔鳞状细胞癌ERK蛋白表达与临床分期、淋巴结转移的关系 被引量:3

Investigation of extracellular signal-regulated protein kinase and lymphnode metastasis in oral squamous cell carcinoma
下载PDF
导出
摘要 目的:研究有丝分裂活化蛋白激酶ERK表达与口腔鳞癌(OSCC)临床分期、癌细胞分化程度及淋巴结转移的关系。方法:采用SP免疫组织化学方法检测41例OSCC组织中ERK蛋白的表达,数据采用t检验进行显著性比较,Logistic回归分析。结果:ERK蛋白表达强度随OSCC临床分期的提高而增强(P<0.01);OSCC中ERK蛋白表达强度与淋巴结转移密切相关(P<0.05);OSCC中ERK蛋白表达强度与癌细胞分化程度无关(P>0.05)。结论:ERK蛋白表达与口腔鳞癌的发生及进展密切相关,是患者预后的重要指标之一。 PURPOSE: To study the relationship between the expression of extracellular signal-regulated protein kinase (ERK) and the differentiation degree and lymphnode metastasis in oral squamous cell carcinoma. METHODS: Immunohistochemical staining was used in 41 cases of OSCC to investigate the expression of ERK protein. Student's t test were used for statistical analysis. RESULTS: A significant relationship was observed between the expression intensity of ERK protein and clinicopathological features of OSCC(P<0.01). A significant relationship was observed between the expression intensity of ERK protein and lymph node metastasis of OSCC(P<0.05). No correlation between the expression intensity of ERK protein and cell differentiation degree of OSCC(P>0.05) was found. CONCLUSIONS: Activation of ERK may play a strong role in the development of OSCC. Intensive expression of ERK protein may be an important presage marker in OSCC patients.
出处 《上海口腔医学》 CAS CSCD 2005年第1期18-20,共3页 Shanghai Journal of Stomatology
关键词 有丝分裂活化蛋白激酶 口腔鳞癌 免疫组化 ERK Oral squamous cell carcinoma Immunohistochemical assay
  • 相关文献

参考文献5

  • 1叶定伟,李慧,Priscilla Chauvin,孙颖浩,钱松溪,郑家富,马永江.有丝分裂激活蛋白激酶激活与前列腺癌的恶化进展[J].肿瘤防治杂志,2002,9(2):157-158. 被引量:14
  • 2Johnson GL, Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases[J]. Science,2002,298(5600):1911-1912.
  • 3Bresalier RS, Ho SB, Schoeppner HL, et al. Enhanced sialylation of mucin-associated carbohydrate structures in human colon cancer metastasis[J]. Gastroenterology, 1996, 110(5):1354-1367.
  • 4Patton SE, Martin ML, Nelsen LL, et al. Activation of the rasmitogen-activated protein kinase pathway and phosphorylation of ets-2 at position threonine 72 in human ovarian cancer cell lines [J]. Cancer Res, 1998, 58(10):2253-2259.
  • 5Simon C, Hicks MJ, Nemechek AJ, et al. PD098059, an inhibitor of ERK1 activation, attenuates the in vivo invasiveness of head and neck squamous cell carcinoma[J]. Br J Cancer, 1999, 80(9):1412-1419.

二级参考文献2

共引文献13

同被引文献19

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部